These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9600662)

  • 1. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats.
    Niki H; Yamada M; Yamaki K; Mue S; Ohuchi K
    Eur J Pharmacol; 1998 Mar; 344(2-3):261-7. PubMed ID: 9600662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor.
    Wakitani K; Nanayama T; Masaki M; Matsushita M
    Jpn J Pharmacol; 1998 Nov; 78(3):365-71. PubMed ID: 9869271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
    Wakitani K; Tazaki H; Matsushita M; Iwamura H
    Inflamm Res; 2000 Mar; 49(3):117-22. PubMed ID: 10807499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
    Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
    Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible participation of cyclooxygenase-2 in the recurrence of allergic inflammation in rats.
    Niki H; Tominaga Y; Watanabe-Kobayashi M; Mue S; Ohuchi K
    Eur J Pharmacol; 1997 Feb; 320(2-3):193-200. PubMed ID: 9059854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
    Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
    Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1.
    Yamamoto H; Kondo M; Nakamori S; Nagano H; Wakasa K; Sugita Y; Chang-De J; Kobayashi S; Damdinsuren B; Dono K; Umeshita K; Sekimoto M; Sakon M; Matsuura N; Monden M
    Gastroenterology; 2003 Aug; 125(2):556-71. PubMed ID: 12891558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
    Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
    Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
    Wei M; Morimura K; Wanibuchi H; Shen J; Salim EI; Moku M; Hakoi K; Fukushima S
    Int J Cancer; 2005 Jan; 113(3):354-8. PubMed ID: 15455344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries.
    Yamada M; Numaguchi Y; Okumura K; Harada M; Naruse K; Matsui H; Ito T; Hayakawa T
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):256-62. PubMed ID: 11834525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 participates in the late phase of airway hyperresponsiveness after ozone exposure in guinea pigs.
    Nakano H; Aizawa H; Matsumoto K; Fukuyama S; Inoue H; Hara N
    Eur J Pharmacol; 2000 Sep; 403(3):267-75. PubMed ID: 10973629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by auranofin of the production of prostaglandin E2 and nitric oxide in rat peritoneal macrophages.
    Yamashita M; Ichinowatari G; Yamaki K; Ohuchi K
    Eur J Pharmacol; 1999 Mar; 368(2-3):251-8. PubMed ID: 10193662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).
    Hashimoto H; Imamura K; Haruta J; Wakitani K
    J Med Chem; 2002 Mar; 45(7):1511-7. PubMed ID: 11906292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
    Wei M; Morimura K; Wanibuchi H; Shen J; Doi K; Mitsuhashi M; Moku M; Salim EI; Fukushima S
    Cancer Lett; 2003 Dec; 202(1):11-6. PubMed ID: 14643021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro.
    Shimada K; Yonetani Y; Kita T; Suzumura A; Takayanagi T; Nakashima T
    Eur J Pharmacol; 1998 Aug; 356(1):73-80. PubMed ID: 9761426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
    Chan CC; Rodger IW
    Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK; Hirasawa N; Niki H; Ohuchi K
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.